Amicus Therapeutics (FOLD) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Amicus Therapeutics (FOLD) over the last 10 years, with Q3 2025 value amounting to $8.1 million.
- Amicus Therapeutics' Change in Receivables fell 646.77% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year decrease of 2401.87%. This contributed to the annual value of $19.5 million for FY2024, which is 310.32% down from last year.
- Per Amicus Therapeutics' latest filing, its Change in Receivables stood at $8.1 million for Q3 2025, which was down 646.77% from $12.5 million recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Change in Receivables ranged from a high of $12.5 million in Q2 2025 and a low of -$15.3 million during Q1 2025
- In the last 5 years, Amicus Therapeutics' Change in Receivables had a median value of $3.4 million in 2022 and averaged $3.7 million.
- Per our database at Business Quant, Amicus Therapeutics' Change in Receivables soared by 61006.56% in 2021 and then tumbled by 79912.22% in 2024.
- Quarter analysis of 5 years shows Amicus Therapeutics' Change in Receivables stood at $1.8 million in 2021, then skyrocketed by 445.07% to $9.9 million in 2022, then grew by 16.05% to $11.5 million in 2023, then fell by 9.57% to $10.4 million in 2024, then dropped by 22.22% to $8.1 million in 2025.
- Its Change in Receivables stands at $8.1 million for Q3 2025, versus $12.5 million for Q2 2025 and -$15.3 million for Q1 2025.